House Republicans on Tuesday introduced legislation to end the COVID-19 public health emergency, coming about three years after it was implemented nationwide.
The U.S. Department of Health and Human Services (HHS) on Wednesday confirmed it has extended the federal COVID-19 state of emergency.
The U.S. House of Representatives on Dec. 8 passed a defense funding bill that would force the termination of the military’s COVID-19 vaccine mandate if it is also approved by the Senate and signed by President Joe Biden.
The U.S. Centers for Disease Control and Prevention (CDC) on Monday made another sweeping change to one of its pandemic-era responses.
The vaccine mandate for federal employees will remain blocked at least until a September court hearing.
President Joe Biden’s administration plans to extend the emergency declaration over COVID-19 before it expires, an official indicated on June 16.
A watchdog seeking records from President Joe Biden’s administration on the rationing of a key COVID-19 treatment is suing the government for not providing the records in a timely manner.
WASHINGTON—U.S. regulators have historically inspected baby formula plants at least once a year, but they did not inspect any of the three biggest manufacturers in 2020, according to federal records reviewed by The Associated Press.
Moderna Inc has made all necessary submissions required by the U.S. Food & Drug Administration for emergency use authorization of its COVID-19 vaccine in adolescents and children, it said on Wednesday.
The United States will share technologies used to make COVID-19 vaccines through the World Health Organization and is working to expand rapid testing and antiviral treatments for hard-to-reach populations, President Joe Biden said on Thursday.
An officer in the Army was found guilty in military court this week of disobeying COVID-19 rules, but the judge in the case imposed no punishment.
WASHINGTON—Moderna Inc.’s chief medical officer said on Sunday the company’s vaccine for children under 6 years old will be ready for review by a Food and Drug Administration (FDA) panel when it meets in June.